Although adding such adjustments would not affect the associations of risk, as they are all highly significant, the reported difference in OR estimates between BRAF ‐mutated and nonmutated tumors would fall slightly below the significance threshold (accounting for tests of four different subtypes).
← all excerpts
Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases.
1
—
—